curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Modular Neurological Examination for Early Risk Detection

by palligoelme@gmail.com | Apr 16, 2026 | Clinical Trials

​ Conditions: Clinical Practice Guidelines; Neurological Development Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Active, not recruiting Conditions: Clinical Practice Guidelines; Neurological Development Sponsors: Fondazione Policlinico...

Quadriceps and Hamstring Activation Timing

by palligoelme@gmail.com | Apr 16, 2026 | Clinical Trials

​ Conditions: Anterior Cruciate Ligament Reconstruction; Knee Injury; Neuromuscular Control Interventions: Diagnostic Test: Electromyography Sponsors: KTO Karatay University Enrolling by invitation Conditions: Anterior Cruciate Ligament Reconstruction; Knee Injury;...

Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer

by palligoelme@gmail.com | Apr 16, 2026 | Clinical Trials

​ Conditions: Bladder Tumor (TURBT) Interventions: Procedure: Holmium Laser En-Bloc Resection of Bladder Tumor; Procedure: Conventional Transurethral Resection of Bladder Tumor Sponsors: Beni-Suef University Completed Conditions: Bladder Tumor (TURBT) Interventions:...

Effect of Different Volumes of Erector Spinae Plane Block on Postoperative Opioid Consumption After Total Abdominal Hysterectomy

by palligoelme@gmail.com | Apr 16, 2026 | Clinical Trials

​ Conditions: Postoperative Pain; Abdominal Hysterectomy; Pain Interventions: Procedure: Erector Spinae Plane Block Sponsors: Şule Arıcan Completed Conditions: Postoperative Pain; Abdominal Hysterectomy; Pain Interventions: Procedure: Erector Spinae Plane Block...

A Phase III Study of JSKN016 Versus Treatment of Physician’s Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care

by palligoelme@gmail.com | Apr 16, 2026 | Clinical Trials

​ Conditions: Triple Negative Breast Cancer Interventions: Drug: JSKN016 Injection; Drug: Eribulin Mcsilate Injection; Drug: Vinorelbine Tartrate Injection; Drug: Capecitabine Tablets; Drug: Gemcitabine Hydrochloride for Injection; Drug: Sacituzumab Govitecan for...
« Older Entries

Recent Posts

  • A Phase III Study of JSKN016 Versus Treatment of Physician’s Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care
  • Effect of Different Volumes of Erector Spinae Plane Block on Postoperative Opioid Consumption After Total Abdominal Hysterectomy
  • Holmium Laser En-Bloc Resection Versus Conventional Transurethral Resection of Bladder Tumors for Treatment of Non-muscle- Invasive Bladder Cancer
  • Quadriceps and Hamstring Activation Timing
  • Modular Neurological Examination for Early Risk Detection

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®